Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study

Haiying Sun, Ruoqi Ning, Yu Tao, Chong Yu, Xiaoyan Deng, Caili Zhao, Silu Meng, Fangxu Tang, Dong Xu, Haiying Sun, Ruoqi Ning, Yu Tao, Chong Yu, Xiaoyan Deng, Caili Zhao, Silu Meng, Fangxu Tang, Dong Xu

Abstract

Background/objectives: Previous studies have reported that older patients may experience worse outcome(s) after infection with severe acute respiratory syndrome coronavirus-2 than younger individuals. This study aimed to identify potential risk factors for mortality in older patients with coronavirus disease 2019 (COVID-19) on admission, which may help identify those with poor prognosis at an early stage.

Design: Retrospective case-control.

Setting: Fever ward of Sino-French New City Branch of Tongji Hospital, Wuhan, China.

Participants: Patients aged 60 years or older with COVID-19 (n = 244) were included, of whom 123 were discharged and 121 died in hospital.

Measurements: Data retrieved from electronic medical records regarding symptoms, signs, and laboratory findings on admission, and final outcomes of all older patients with COVID-19, were retrospectively reviewed. Univariate and multivariate logistic regression analyses were used to explore risk factors for death.

Results: Univariate analysis revealed that several clinical characteristics and laboratory variables were significantly different (ie, P < .05) between discharged and deceased patients. Multivariable logistic regression analysis revealed that lymphocyte (LYM) count (odds ratio [OR] = 0.009; 95% confidence interval [CI] = 0.001-0.138; P = .001) and older age (OR = 1.122; 95% CI = 1.007-1.249; P = .037) were independently associated with hospital mortality. White blood cell count was also an important risk factor (P = .052). The area under the receiver operating characteristic curve in the logistic regression model was 0.913. Risk factors for in-hospital death were similar between older men and women.

Conclusion: Older age and lower LYM count on admission were associated with death in hospitalized COVID-19 patients. Stringent monitoring and early intervention are needed to reduce mortality in these patients. J Am Geriatr Soc 68:E19-E23, 2020.

Keywords: COVID-19; mortalityolder patientsrisk factors.

Conflict of interest statement

The authors have no conflicts.

© 2020 The American Geriatrics Society.

Figures

Figure 1
Figure 1
Receiver operating characteristic (ROC) curves for univariate and multivariate logistic regression models of risk factors. The purple curve is the ROC curve for the logistic regression model of age alone. The red curve is the ROC curve of the logistic regression model of lymphocyte (LYM) count alone. The blue curve is the ROC curve for the multivariable logistic regression model.

References

    1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92:401‐402.
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497‐506.
    1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565‐574.
    1. World Health Organization . Coronavirus Disease (COVID‐19) Pandemic. . Accessed April 22, 2020.
    1. National Health Commission of the Peopleʼs Republic of China . Update on COVID‐19 as of 24:00 on 5 March. . Accessed April 22, 2020.
    1. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID‐19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. 10.1007/s00134-020-05991-x. [Epub ahead of print].
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA. 2020;323:1061. 10.1001/jama.2020.1585.
    1. Chong CP, Street PR. Pneumonia in the elderly: a review of the epidemiology, pathogenesis, microbiology, and clinical features. South Med J. 2008;101:1141‐1145.
    1. Marrie TJ. Community‐acquired pneumonia in the elderly. Clin Infect Dis. 2000;31:1066‐1078.
    1. Shu J. Pneumonia in the elderly: understanding the characteristics. South Med J. 2008;101:1086.
    1. Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1:253‐260.
    1. Heo JY, Song JY, Noh JY, et al. Effects of influenza immunization on pneumonia in the elderly. Hum Vaccin Immunother. 2018;14:744‐749.
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054‐1062.
    1. Li R, Qiao S, Zhang G. Analysis of angiotensin‐converting enzyme 2 (ACE2) from different species sheds some light on cross‐species receptor usage of a novel coronavirus 2019‐nCoV. J Infect. 2020;80:469‐496.
    1. Koitka A, Cooper ME, Thomas MC, Tikellis C. Angiotensin converting enzyme 2 in the kidney. Clin Exp Pharmacol Physiol. 2008;35:420‐425.
    1. Huang ML, Li X, Meng Y, et al. Upregulation of angiotensin‐converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clin Exp Pharmacol Physiol. 2010;37:e1‐e6.
    1. Wang W, Song A, Zeng Y, et al. Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin‐angiotensin system activity. BMC Cardiovasc Disord. 2018;18:133.
    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507‐513.

Source: PubMed

3
Subskrybuj